Jeff Ajer
2013
In 2013, Jeff Ajer earned a total compensation of $2.7M as Executive Vice President, Chief Commercial Officer at BioMarin Pharmaceutical, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,712 |
|---|---|
| Option Awards | $1,522,430 |
| Salary | $382,688 |
| Stock Awards | $569,604 |
| Other | $7,563 |
| Total | $2,667,997 |
Ajer received $1.5M in option awards, accounting for 57% of the total pay in 2013.
Ajer also received $185.7K in non-equity incentive plan, $382.7K in salary, $569.6K in stock awards and $7.6K in other compensation.
Rankings
In 2013, Jeff Ajer's compensation ranked 2,904th out of 12,286 executives tracked by ExecPay. In other words, Ajer earned more than 76.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,904 out of 12,286 | 76th |
Division Manufacturing | 962 out of 4,614 | 79th |
Major group Chemicals And Allied Products | 253 out of 1,466 | 83rd |
Industry group Drugs | 171 out of 1,160 | 85th |
Industry Pharmaceutical Preparations | 141 out of 890 | 84th |
Source: SEC filing on April 25, 2016.
Ajer's colleagues
We found five more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2013.
2013
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2013
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2013
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2013
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2013
G Davis
BioMarin Pharmaceutical
General Counsel
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019